Galmed Pharmaceuticals (GLMD) EPS (Basic) (2013 - 2025)
Galmed Pharmaceuticals (GLMD) posted quarterly EPS (Basic) of $0.0 for Q2 2025, down 94.93% year-over-year from $0.0 in Q2 2024, and down 94.93% quarter-over-quarter from $0.0 in Q2 2024.
Galmed Pharmaceuticals (GLMD) EPS (Basic) (2013 - 2025) Analysis & Trends
Galmed Pharmaceuticals' EPS (Basic) history runs 13 years deep, the most recent figure standing at $0.0 for Q2 2025.
- In Q2 2025, EPS (Basic) fell 94.93% year-over-year to $0.0; the TTM figure through Mar 2026 stood at $0.0 (down 91.76% YoY), while the FY2025 annual figure was $0.07, down 81.95% from the prior year.
- EPS (Basic) for Q2 2025 stood at $0.0, down from $0.0 in the prior quarter.
- The five-year high for EPS (Basic) was $1.61 in Q2 2022, with the low at -$0.76 in Q3 2022.
- The 5-year median for EPS (Basic) is $0.0 (2023), against an average of $0.47.
- The sharpest annual moves came in 2021 and 2022: EPS (Basic) slumped 50.77% in 2021, then sank 157.92% in 2022.
- Galmed Pharmaceuticals' EPS (Basic) stood at $1.31 in 2021, then slumped by 157.92% to -$0.76 in 2022, then jumped by 100.0% to $0.0 in 2023, then slumped by 53.64% to $0.0 in 2024, then plunged by 94.93% to $0.0 in 2025.
- Business Quant data shows GLMD's EPS (Basic) at $0.0 in Q2 2025, $0.0 in Q2 2024, and $0.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.65 Bn | 131.79 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 86.08 Bn | 78.09 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 65.16 Bn | 59.98 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 63.25 Bn | 58.11 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.26 Bn | 27.95 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.96 Bn | 10.57 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.19 Bn | 26.35 Bn | - | 0.18 |
| 10 | Galmed Pharmaceuticals | 2.39 Mn | -9.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Sep 30, 2022 | -0.76 |
| Jun 30, 2022 | 1.61 |
| Sep 30, 2021 | 1.31 |
| Mar 31, 2021 | 1.10 |
| Dec 31, 2020 | -3,453.64 |
| Sep 30, 2020 | 3,471.78 |
| Jun 30, 2020 | -44.59 |
| Mar 31, 2020 | 2.23 |
| Dec 31, 2019 | 711.50 |
| Sep 30, 2019 | -0.09 |
| Jun 30, 2019 | -0.14 |
| Mar 31, 2019 | -0.36 |
| Dec 31, 2018 | 36.78 |
| Sep 30, 2018 | 9.27 |
| Jun 30, 2018 | -0.08 |
| Mar 31, 2018 | 0.42 |
| Dec 31, 2017 | 52.53 |